Clinical Trial

TH-CAR-027 for Grade 4 Gliomas

Name: TH-CAR-027 for Grade 4 Gliomas — clinical trial record (NCT07384390)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Early Phase 1

View on ClinicalTrials.gov →

Summary

This is an open-Label, dose-escalation, multiple administration, exploratory clinical study to evaluate the safety, tolerability, and anti-tumor activity of TH-CART-027 cell injection in subjects with recurrent or progressive grade 4 glioma

Protocol Amendment History 1 amendment

This ClinicalTrials.gov record has been amended once since 2026-01-26.

Trial Details

NCT Number	NCT07384390
Lead Sponsor	Shanghai Tongji Hospital, Tongji University School of Medicine
Conditions	R/R Grade 4 Glioma
Enrollment	21 participants
Start Date	2026-01-30
Primary Completion	2028-08-31 (estimated)
Study Completion	2029-08-31 (estimated)
Updated on ClinicalTrials.gov	2026-02-04